The market for smoking cessation therapy is expected to grow at a CAGR of around 15.7% from 2020 to 2027 and expected to reach the market value of around US$ 43.6 Bn by 2027.
Smoking cessation therapy is the process of discontinuing tobacco smoking addiction. Tobacco smoke contains nicotine which is addictive, and sudden withdrawal from it can often make the process of smoking cessation therapy difficult. One of the major ways helps in smoking cessation include nicotine replacement therapy or the replacement of the nicotine consumption with other means like nicotine gum, lozenges, nasal sprays, or inhalers, that can avoid trigger situations like urge to smoke. Additionally, some of the major benefits associated with the smoking cessation include better health, betting family, and money saving among others. Moreover, the popularity of electronic cigarettes or e-cigarettes among the population as an alternative of smoking is supporting the smoking cessation initiatives.
Market Dynamics
The increasing government initiatives to implement the anti-smoking policy and to spread awareness regarding the health complications associated with smoking, The World Health Organization (WHO) has initiated a program named ‘Tobacco Free Initiative’, which includes the implementation of plain packaging, particularly to reduce the attractiveness of the product, additionally the screening of documentaries and videos to inform the public about the hazards of smoking. The use of tobacco can lead to tobacco/nicotine dependence and serious health problems. As tobacco smoke contains a deadly mix of more than 7,000 chemicals, hundreds of them are harmful, and about 70 can cause cancer. Whereas, quitting smoking reduces the risk of developing smoking-related diseases. The Food and Drug Administration (US) has launched an adult smoking cessation therapy education campaign in 2017 aimed at encouraging cigarette smokers to stop smoking. According to the Centers for Disease Control and Prevention (CDC), in 2017, 14 of every 100 US adults aged 18 years or older (14.0%) smoke cigarettes.
On the other hand, the strong dependency of smokers on smoking cravings and side effects associate with smoking cessation like headaches, nausea, tingling in hands and feet, irritability, frustration, anger, and constipation are restraining the growth in the market.
Segment Instance
North America registered maximum revenue share in the Smoking cessation therapy Market
In 2019, North America accounted for the maximum revenue share (%), and the region is also projected to maintain its dominance over the forecast period from 2020 to 2027. The increasing initiatives for spreading awareness about stopping smoking by the major authorities like FDA and WHO are supporting the regional market value. The large percentage of people in US is involved in smoking is the factor supporting the regional market value. According to the 2019 data of U.S. Department of Health & Human Services, around 34.1 million adults in the United States smoke cigarettes and more than 16 million Americans live with a smoking-related disease. Furthermore, Asia Pacific is projected to exhibit the fastest growth (%) over the forecast period from 2020 to 2027. The developing economies including China and India are supporting the regional market growth during the estimated period.
Key Market Players
The players profiled in the report include Bayer AG (Germany), Cipla Ltd (India), F. Hoffmann-La Roche AG (Switzerland), GlaxoSmithKline plc (UK), Imperial Tobacco Ltd. (UK), Johnson and Johnson (US), NJOY (US), Novartis AG (Switzerland), Pfizer, Inc. (US), Reckitt Benckiser Plc (UK), Revolymer plc, Takeda Pharmaceutical Company Ltd. (Japan), VMR Products, LLC. (US), and others.
Market Segmentation
Market By Product
Nicotine Replacement Therapy
- NRT Gum
- NRT lozenges
- NRT Inhalers
- NRT Patches
- Sprays
Drugs
Electronic Cigarettes
Others
Market By Sales Channel
Hospital Pharmacies
Online Channel
Retail Pharmacies
Other Sales Channel
Market By Geography
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Smoking Cessation Therapy
1.1. Definition and Scope
1.1.1. Definition of Smoking Cessation Therapy
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Smoking Cessation Therapy Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Smoking Cessation Therapy Market By Product
1.2.3. Smoking Cessation Therapy Market By Sales Channel
1.2.4. Smoking Cessation Therapy Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Smoking Cessation Therapy Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Smoking Cessation Therapy Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2019
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of Smoking Cessation Therapy Major Manufacturers in 2019
CHAPTER 5. Smoking Cessation Therapy Market By Product
5.1. Introduction
5.2. Smoking Cessation Therapy Revenue By Product
5.2.1. Smoking Cessation Therapy Revenue (US$ Mn) and Forecast, By Product, 2016-2027
5.2.2. Nicotine Replacement Therapy
5.2.2.1. Nicotine Replacement Therapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.1. NRT Gum
5.2.2.1.1.1. NRT Gum Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.2. NRT lozenges
5.2.2.1.2.1. NRT lozenges Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.3. NRT Inhalers
5.2.2.1.3.1. NRT Inhalers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.4. NRT Patches
5.2.2.1.4.1. NRT Patches Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.5. Sprays
5.2.2.1.5.1. Sprays Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Drugs
5.2.3.1. Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Electronic Cigarettes
5.2.4.1. Electronic Cigarettes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Others
5.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Smoking Cessation Therapy Market Revenue By Sales Channel
6.1. Introduction
6.2. Smoking Cessation Therapy Revenue (US$ Mn) By Sales Channel
6.2.1. Smoking Cessation Therapy Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
6.2.2. Hospital Pharmacies
6.2.2.1. Hospital Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Online Channel
6.2.3.1. Online Channel Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Retail Pharmacies
6.2.4.1. Retail Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Others
6.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. North America Smoking Cessation Therapy Market By Country
7.1. North America Smoking Cessation Therapy Overview
7.2. U.S.
7.2.1. U.S. Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
7.2.2. U.S. Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016-2027
7.3. Canada
7.3.1. Canada Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
7.3.2. Canada Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016-2027
7.4. North America PEST Analysis
CHAPTER 8. Europe Smoking Cessation Therapy Market By Country
8.1. Europe Smoking Cessation Therapy Market Overview
8.2. U.K.
8.2.1. U.K. Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.2.2. U.K. Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016-2027
8.3. Germany
8.3.1. Germany Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.3.2. Germany Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016-2027
8.4. France
8.4.1. France Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.4.2. France Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016-2027
8.5. Spain
8.5.1. Spain Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.5.2. Spain Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.6.2. Rest of Europe Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016-2027
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Smoking Cessation Therapy Market By Country
9.1. Asia Pacific Smoking Cessation Therapy Market Overview
9.2. China
9.2.1. China Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.2.2. China Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
9.3. Japan
9.3.1. Japan Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.3.2. Japan Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
9.4. India
9.4.1. India Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.4.2. India Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
9.5. Australia
9.5.1. Australia Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.5.2. Australia Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
9.6. South Korea
9.6.1. South Korea Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.6.2. South Korea Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.7.2. Rest of Asia-Pacific Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Smoking Cessation Therapy Market By Country
10.1. Latin America Smoking Cessation Therapy Market Overview
10.2. Brazil
10.2.1. Brazil Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.2.2. Brazil Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
10.3. Mexico
10.3.1. Mexico Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.3.2. Mexico Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
CHAPTER 11. Middle East & Africa Smoking Cessation Therapy Market By Country
11.1. Middle East & Africa Smoking Cessation Therapy Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.2.2. Saudi Arabia Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
11.3. UAE
11.3.1. UAE Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.3.2. UAE Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.4.2. Rest of Middle East & Africa Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
CHAPTER 12. Player Analysis Of Smoking Cessation Therapy
12.1. Smoking Cessation Therapy Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Smoking Cessation Therapy Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. COMPANY PROFILE
13.1. Bayer AG (Germany)
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. Bayer AG (Germany) 2019 Smoking Cessation Therapy Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. Cipla Ltd (India)
13.3. F. Hoffmann-La Roche AG (Switzerland)
13.4. GlaxoSmithKline plc (UK)
13.5. Imperial Tobacco Ltd. (UK)
13.6. Johnson and Johnson (US)
13.7. NJOY (US)
13.8. Novartis AG (Switzerland)
13.9. Pfizer, Inc. (US)
13.10. Reckitt Benckiser Plc (UK)
13.11. Revolymer plc
13.12. Takeda Pharmaceutical Company Ltd. (Japan)
13.13. VMR Products, LLC. (US)
13.14. Others
![Smoking cessation therapy Market (By Product: Nicotine Replacement Therapy [Gum, lozenges, Inhalers, Patches, Sprays], Drugs, Electronic Cigarettes, Others; By Sales Channel: Hospital Pharmacies, Online Channel, Retail Pharmacies, Other) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027](assets/images/format-png.png "Smoking cessation therapy Market (By Product: Nicotine Replacement Therapy [Gum, lozenges, Inhalers, Patches, Sprays], Drugs, Electronic Cigarettes, Others; By Sales Channel: Hospital Pharmacies, Online Channel, Retail Pharmacies, Other) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027")
